Second Window Indocyanine Green for All Nervous System Tumors
Clinical trial NCT05746104 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05746104
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-31
- Primary completion
- 2027-02-15
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.